A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 11, Issue 3, 1991, Pages 540-546

  Green, Fiona ^a   Kelleher, Cecily ^b   Wilkes, Helen ^b   Temple, Anne ^a   Meade, Tom ^b   Humphries, Steve ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

Factor VII; Genetic polymorphisms; Ischemic heart disease; Myocardial infarction; Polymerase chain reaction; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 7;

ADULT; ARTICLE; FEMALE; GENETIC POLYMORPHISM; HEMOSTASIS; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOSIS;

AGED; ANTIGENS; ARGININE; BASE SEQUENCE; CODON; DEOXYRIBONUCLEASE HPAII; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; FACTOR VII; FEMALE; GENE FREQUENCY; GENOTYPE; GLUTAMINE; HUMAN; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM (GENETICS); PROTEIN CONFORMATION; SUPPORT, NON-U.S. GOV'T;

EID: 0025860324     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.11.3.540     Document Type: Article

References (37)

1. Long GL: Structure and evolution of the human genes encoding protein C and coagulation factors VII, IX and X. Cold Spring Harb Symp Quant Biol 1986;51:525-529
2. Broze GJ Jr, Majerus PW: Purification and properties of human coagulation Factor VII. J Biol Chem 1980;255: 1242-1247
3. Rao LMR, Rapaport SI: Activation of factor VII bound to tissue factor: A key early step in the tissue factor pathway of blood coagulation. Proc Natl Acad Sci USA 1988;85:6687-6691
4. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG: Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 1986;2:533-537
5. Balleisen L, Schulte H, Assmann G, Epping P-H, Van de Loo J: Coagulation factors and the progress of coronary heart disease. Lancet 1987;2:461
6. Hamsten A, Blomback M, Wiman B, Svensson J, Szamosi A, de Faire U, Mettinger L: Haemostatic function in myocardial infarction. Br Heart J 1986;55:58-66
7. Handa K, Kono S, Saku K, Sasaki J, Kawano T, Sasaki Y, Hiroki T, Arakawa K: Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis. Atherosclerosis 1989;77:209-213
8. Wilhelmsen L, Svardsudd K, Korsan-Bengtsson K, Larsson B, Welin L, Tibblin G: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-505
9. Stone MC, Thorpe JM: Plasma fibrinogen: A major coronary risk factor. J R Coll Gen Pract 1985;35:565-569
10. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB: Fibrinogen and risk of cardiovascular disease: The Framingham Study. JAMA 1987;258:1183-1186
11. Hamsten A, de Faire U, Walldius G, Dahlen G, Szamosi A, Landou C, Blomback M, Wiman B: Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction. Lancet 1987;2:3-9
12. Mitropoulos KA, Esnouf MP, Meade TW: Increased Factor VII coagulant activity in the rabbit following diet-induced hypercholesterolaemia. Atherosclerosis 1987;63:43-52
13. Mitropoulos KA, Esnouf MP: Turnover of factor X and of prothrombin in rabbits fed on a standard or cholesterol-supplemented diet. Biochem J 1987;244:263-269
14. Miller GJ, Walter SJ, Stirling Y, Thompson SG, Esnouf MP, Meade TW: Assay of Factor VII activity by two techniques: Evidence for increased conversion of VII to α-VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease. Br J Haematol 1985;59:249-258
15. Miller GJ, Martin JC, Webster J, Wilkes H, Miller NE, Wilkinson WH, Meade TW: Association between dietary fat intake and plasma Factor VII coagulant activity, a predictor of cardiovascular mortality. Atherosclerosis 1986;60:269-277
16. Mitropoulos KA, Miller GJ, Reeves BEA, Wilkes HC, Cruickshank JK: Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men. Atherosclerosis 1989;76:203-208
17. Miller GJ, Cruickshank JK, Ellis LJ, Thompson RL, Wilkes HC, Stirling Y, Mitropoulos KA, Allison JV, Fox TE, Walker AO: Fat consumption and Factor VII coagulant activity in middle aged men: An association between a dietary and thrombogenic coronary risk factor. Atherosclerosis 1989;78: 19-24
18. Meade TW, North WRS: Population based distributions of haemostatic variables. Br Med Bull 1977;33:283-288
19. Balliesen L, Bailey J, Epping PH, Schulte H, van de Loo J: Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pillusing, and menopause. Thromb Haemost 1985;54:475-479
20. Meade TW, Imeson J, Stirling Y: Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987;2:986-990
21. Thompson SG, Martin JC, Meade TW: Sources of variability in coagulation factor assays. Thromb Haemost 1989;58: 1073-1077
22. Biggs R, Eveling J, Richards G: The assay of antihaemophiliac globulin activity. Br Heart J 1955;1:20
23. Hagen FS, Gray CL, O'Hara P, Grant FJ, Saari GC, Woodbury RG, Hart CE, Insley M, Kisiel W, Kurachi K, Davie EW: Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci USA 1986;83:2412-2416
24. O'Hara PJ, Grant FJ, Haldeman BA, Gray CL, Insley MY, Hagen FS, Murray MJ: Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc Natl Acad Sci USA 1987;84:5158-5162
25. Ott R, Pfeiffer RA: Evidence that activities of coagulation factors VII and X are linked to chromosome 13(q34). Hum Hered 1984;34:123-126
26. de Grouchy J, Dautzenberg M-D, Turleau C, Beguin S, Chavin-Colin F: Regional mapping of clotting factors CII and X to 13q34. Hum Genet 1984;66:230-233
27. Humphries SE, Cook M, Dubowitz M, Stirling Y, Meade TW: Role of genetic variation of the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet 1987;1: 1452-1455
28. Meade TW, Wilkes HC, Stirling Y, Brennan PJ, Kelleher C, Browne W: Randomized controlled trial of low dose warfarin in the primary prevention of ischaemic heart disease in men at high risk: Design and pilot study. Eur Heart J 1988;9:836-843
29. Boyer C, Wolf M, Rothschild C, Migaud M, Amiral J, Mannucci PM, Meyer D, Larrieu MJ: An enzyme immunoassay (ELISA) for the quantitation of human factor VII. Thromb Haemost 1986;56:250-255
30. Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OH, Beg WR, Jones HW, Rary JM: Analysis of human Y-chromosome specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 1977;74:1245-1249
31. Feinberg AP, Vogelstein B: Addendum: "A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity." Anal Biochem 1984;137:266-267
32. Girolami A, Falezza G, Patrassi G, Stenico M, Vettore L: Factor VII Verona coagulation disorder: Double heterozygosis with an abnormal factor VII and heterozygous factor VII deficiency. Blood 1977;50:603-617
33. Girolami A, Cattarozzi R, Dal Bo Zanon R, Cella G, Toffanin F: Factor VII Padua2: Another factor VII abnormality with defective ox brain thromboplastin activation and a complex hereditary pattern. Blood 1979;54:46-53
34. van der Loos LJM: Congenital factor VII deficiency. Acta Clin Belg 1987;42:66-67
35. Mikami S, Tuddenham EGD: Studies on immunological assay of vitamin K dependent factors: I. Measurement of factor VII antigen by radioimmunoassay. Br J Haematol 1986;62:171-181
36. Carrell RW, Jeppsson J-O, Laurell C-B, Brennan SO, Owen MC, Vaughan L, Boswell DR: Structure and variation of human α-1-antitrypsin. Nature 1982;298:329-334
37. Soutar AK, Knight BL, Patel DD: Identification of a point mutation in growth factor repeat C of the low density lipoprotein-receptor gene in a patient with homozygous familial hypercholesterolemia that affects ligand binding and intracellular movement of receptors. Proc Natl Acad Sci USA 1989;86:4166-4170